logo-loader

Dyadic International Chairman highlights recent Serum Institute of India collaboration

Published: 23:00 30 May 2019 AEST

Dyadic International Inc (NASDAQ:DYAI) Chairman Michael Tarnok tells Proactive Investors he's been very impressed with the nine collaborations Dyadic has formed in 2018.

In particular, the former Pfizer (NYSE:PFE) sales and marketing executive focuses on Dyadic's most recently announced collaboration with vaccines and immuno-biologics manufacturer Serum Institute of India.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

8 hours, 8 minutes ago